Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Asset Utilization Ratio (2021 - 2025)

Barinthus Biotherapeutics (BRNS) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.01 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Asset Utilization Ratio rose 421.5% year-over-year to 0.01, compared with a TTM value of 0.01 through Jun 2025, up 421.5%, and an annual FY2023 reading of 0.0, down 97.96% over the prior year.
  • Asset Utilization Ratio was 0.01 for Q2 2025 at Barinthus Biotherapeutics, up from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.16 in Q4 2022 and bottomed at 0.0 in Q2 2024.
  • Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.02 recorded in 2021.
  • The sharpest move saw Asset Utilization Ratio soared 16323.46% in 2022, then plummeted 99.1% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.0 in 2021, then surged by 16323.46% to 0.16 in 2022, then tumbled by 99.1% to 0.0 in 2023, then soared by 37.21% to 0.0 in 2024, then soared by 148.78% to 0.01 in 2025.
  • Business Quant data shows Asset Utilization Ratio for BRNS at 0.01 in Q2 2025, 0.0 in Q3 2024, and 0.0 in Q2 2024.